Lobe-specific lymph node dissection in early-stage non-small-cell lung cancer: An overview
Lymph node dissection is a vital part of surgical treatment for early-stage non-small cell lung cancer (NSCLC). Lobectomy with systematic lymph node dissection (SLND) still remains the gold standard surgical treatment for early-stage NSCLC patients. However, an increasing number of studies have demo...
Main Authors: | Lei Peng, Qian-Wen Shang, Han-Yu Deng, Zhen-Kun Liu, Wen Li, Yun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-02-01
|
Series: | Asian Journal of Surgery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1015958422009885 |
Similar Items
-
Identification of Factors Related to the Quality of Lymphadenectomy for Lung Cancer: Secondary Analysis of Prospective Randomized Trial Data
by: Piotr Gabryel, et al.
Published: (2023-05-01) -
Permissible Outcomes of Lobe-Specific Lymph Node Dissection for Elevated Carcinoembryonic Antigen in Non-Small Cell Lung Cancer
by: Hiroaki Kuroda, et al.
Published: (2021-12-01) -
Lobe-Specific Analysis of Sublobar Lung Resection for NSCLC Patients with Tumors ≤ 2 cm
by: Xi Lei, et al.
Published: (2022-07-01) -
The Role of Lymphadenectomy in Early-Stage NSCLC
by: Beatrice Manfredini, et al.
Published: (2023-07-01) -
Editorial: Surgical Selection of Sublobar Resection and Scope of Lymph Node Dissection for Early-Stage Lung Cancer
by: Jiajing Sun, et al.
Published: (2022-05-01)